| Identification | Back Directory | [Name]
2,3-DINOR-11BETA-PROSTAGLANDIN F2ALPHA | [CAS]
240405-20-3 | [Synonyms]
Prostaglandin Impurity 1
ProstaglandinImpurity1-d4
IDKLJIUIJUVJNR-KSJYGFEGSA-N
2,3-dinor-11β-Prostaglandin F2α
2,3-dinor-11β-Prostaglandin F2α
2,3-DINOR-11BETA-PROSTAGLANDIN F2ALPHA
2,3-dinor-11β-Prostaglandin F2α Lipid Maps MS Standard
9ALPHA,11BETA,15S-TRIHYDROXY-2,3-DINOR-PROSTA-5Z,13E-DIEN-1-OIC ACID
2,3 dinor 11β Prostaglandin F2α,2,3dinor11βProstaglandin F2α,2,3-dinor-11β-Prostaglandin F-2α
3-Pentenoic acid, 5-[(1R,2R,3S,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-1-octen-1-yl]cyclopentyl]-, (3Z)- | [Molecular Formula]
C18H30O5 | [MDL Number]
MFCD02259339 | [MOL File]
240405-20-3.mol | [Molecular Weight]
326.43 |
| Hazard Information | Back Directory | [Description]
2,3-dinor-11β-Prostaglandin F2α (2,3-dinor-11β-PGF2α) is a metabolite of PGD2 . Urinary excretion of 2,3-dinor-11β-PGF2α is increased in patients with mast cell activation disease (MCAD) and has been used as a marker of increased PGD2 levels. 2,3-dinor-11 β-PGF2α levels are also increased in the urine of patients with asthma and are positively correlated with impaired lung function. | [Uses]
2,3-Dinor-11beta-prostaglandin F2alpha (2,3-Dinor-11β-PGF2α) is a metabolite of PGD2. Urinary excretion of 2,3-Dinor-11beta-prostaglandin F2alpha is increased in patients with mast cell activation disease (MCAD) and has been used as a marker of increased PGD2 levels. 2,3-Dinor-11beta-prostaglandin F2alpha levels are also increased in the urine of patients with asthma and are positively correlated with impaired lung function. | [Definition]
ChEBI: 2,3-Dinor-11b-PGF2alpha is a prostanoid. | [References]
[1] Liston, et al. J. Biol. Chem. 260(24), 13172-13180 (1985). |
|
| Company Name: |
Boao Pike
|
| Tel: |
010-57798038 15652371397 |
| Website: |
www.biopike.cn |
| Company Name: |
CHEMICAL LAND21
|
| Tel: |
82- 2 -783 - 8063 |
| Website: |
www.chemicalland21.com |
|